Physician profile
Todd E Nixon
NPI 1457378473
$6,503.82
in general payments reported to CMS, 2019-2025
28 companies · $489 in 2025
The $489 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,261 · 2020: $238 · 2021: $801 · 2022: $599 · 2023: $665 · 2024: $451 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,867.78 | 2019-2025 | Epic, Navitor, Esprit |
| Edwards Lifesciences Corporation | $1,162.82 | 2019-2025 | Hemosphere |
| Atricure, INC. | $834.44 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Artivion, INC. | $504.56 | 2021-2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Vascular |
| Medtronic, INC. | $249.79 | 2021-2025 | Corevalve Evolut R, Endurant Iis |
| Endologix LLC | $242.31 | 2019 | |
| Cook Medical LLC | $163.99 | 2019-2020 | |
| Abiomed | $152.29 | 2021-2025 | Impella |
| Getinge USA Sales, LLC | $139.39 | 2019-2023 | Cardioroot |
| Medtronic Vascular, INC. | $137.05 | 2019 | |
| Zimmer Biomet Holdings, INC. | $135.47 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $110.41 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $107.60 | 2019 | |
| Baxter Healthcare | $101.84 | 2021-2023 | Preveleak |
| Haemonetics Corporation | $78.49 | 2024 | Teg6s Hemostasis System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $68.64 | 2020-2024 | Arista Ah Flexitip |
| Lemaitre Vascular, INC. | $55.55 | 2021-2023 | Artegraft Vascular Graft |
| Kls-Martin L.P. | $55.01 | 2019-2023 | |
| Kci USA, INC. | $53.22 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $52.63 | 2019 | |
| Integra Lifesciences Corporation | $40.65 | 2022 | |
| Boston Scientific Corporation | $39.22 | 2019 | |
| Paladin Technology Solutions | $33.02 | 2023 | |
| Ethicon US, LLC | $30.38 | 2019 | |
| Biomerieux INC | $29.93 | 2019 | |
| Bard Access Systems, INC. | $25.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.69 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $14.57 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Nixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.